CurifyLabs has secured Series A funding to expand its operations in the US, strengthen its supply chain and accelerate development of its platform for automated, personalised medicine manufacturing.
Finnish
health technology company CurifyLabs has raised €12 million in a Series A
funding round to expand its operations in the United States and accelerate the
development of its platform for personalised medicine manufacturing. The round
was co-led by Sandwater and HealthCap, with participation from Tesi (Finnish
CurifyLabs' second raise in 14 months: husband-and-wife startup lands $14M to automate personalised medicine — TFN
CurifyLabs raises $14M to 3D-print personalised medicine
Handspring Health lands $19M series B to expand behavioral health model for youth
CurifyLabs raised $14 million in Series A funding just 14 months after its last round, bringing total funding above $19 million.…
Finland's CurifyLabs has raised a $14m Series A to expand in the US, where pharmacies in 21 states use its 3D printers to make…
Everlab Raises AU$65m Series A to Make World-Class Preventative Healthcare Something Everyone Can Access
The new capital will support UK growth and US expansion, alongside the rollout of 01Health's platform for delivering specialist…
The startup combines biomarker testing, longitudinal health data and physician-reviewed AI insights to help users detect risks…
Melbourne healthtech Everlab has raised an oversubscribed AU$65m Series A led by Airtree, funding a UK launch and a push into…
